March 17, 2026 PBC Ireland Partners with C-Path’s Rare Disease Data Platform, Advancing Research Efforts for Primary Biliary Cholangitis TUCSON, Ariz., March 12, 2026 — In a significant step to enhance research efforts for Primary Biliary Cholangitis...
March 10, 2026 New Study on Early Parkinson’s Disease Progression Highlights Vital Role of Patient Focused Drug Development and Real-World Impacts TUCSON, Ariz., March 5, 2026 – Critical Path Institute® (C-Path) applauds the publication of a new study in the Journal of...
March 3, 2026 Critical Path Institute’s Translational Therapeutics Accelerator Awards Grant to Support Development of Novel Nonopioid Pain Therapeutics TUCSON, Ariz., March 3, 2026 — Critical Path Institute’s® (C-Path) Bridging Research and Innovation in Drug Development...
February 28, 2026 The Critical Path Institute Podcast: Connecting the Dots in Rare and Pediatric Diseases with VP Collin Hovinga In this episode of the Critical Path Institute© Podcast, C-Path VP of Rare/Orphan and Pediatric Disease Programs Collin...
February 26, 2026 Amidst Rare Disease Awareness Month, C-Path Shines a Light on Listening As a Form of Precision Medicine This perspective builds on insights shared during C-Path’s Global Impact Conference 2025 panel, “Ensuring a Focus on...”
February 20, 2026 What Collaboration Makes Possible On a Tuesday afternoon in the fall of 2019, a biostatistician from a pharmaceutical company...
February 12, 2026 Building the Infrastructure of Hope Medical history is usually written as a chronicle of individual breakthroughs. We learn about Fleming discovering penicillin...
February 10, 2026 The Critical Path Institute Podcast: Electronic Clinical Outcome Assessments in Oncology Research This panel discussion, hosted by C-Path's Electronic Clinical Outcome Assessment Executive Director Scottie Kern...
February 1, 2026 Turning the Impossible into the POSSIBLE February is Rare Disease Month. It is a time when the global community unites to support the 350 million people worldwide...
January 28, 2026 C-Path’s New Clinical Pharmacology & Therapeutics Publication Highlights Real-World Impact of FDA-Qualified Urine Biomarkers for Earlier Detection of Drug-Induced Kidney Injury C-Path) Predictive Safety Testing Consortium today announced the publication of a new peer-reviewed...